Daily Digestive Health Snap PolySure™ Validated Honey Matrix Māori-Led · New Zealand

Gut health,
engineered from nature.

GI-PRO™ is Mānuka Performance's proprietary honey snap — a validated, PolySure™-certified Mānuka & Rewarewa honey matrix combined with 2 billion CFU of BC30™ (Bacillus coagulans GBI-30, 6086®) per serve. One daily snap, no pills, no powders — a science-backed, FDA-compliant digestive health product built for the US wellness consumer.

The honey isn't a flavour vehicle — it's an active co-factor. Naturally occurring prebiotic carbohydrates and polyphenols prime the gut and enhance BC30™'s delivery, while our MPS PolySure™ standard certifies the polyphenol matrix on every batch. This is what separates GI-PRO™ from a probiotic capsule or a jar of honey alone.

2B CFU
BC30™ per serve — corrected from prior 2M CFU labelling
FDA GRAS
BC30™ generally recognized as safe
45+
Published papers backing BC30™ safety & efficacy
7
Certified polyphenols per batch (PolySure™)
GI-PRO by Mānuka Performance — 30-pack retail box and single-serve honey snap
GI-PRO™ — 30-Pack Retail Box & Single-Serve Snap
What GI-PRO™ Is

Not a honey snack.
A validated digestive health product.

A single formulation, built for one job: daily, defensible, science-backed digestive health support for the US consumer.

GI-PRO single-serve pack showing MPS PolySure certification
Single-Serve Pack — MPS PolySure™ Certified
The Formulation
Mānuka + Rewarewa Honey, BC30™ Probiotic

Each GI-PRO™ snap combines New Zealand Mānuka and Rewarewa honey — chosen for their naturally occurring prebiotic carbohydrates, minerals, and polyphenols — with 2 billion CFU of BC30™ (Bacillus coagulans GBI-30, 6086®), a safe, spore-forming, science-backed probiotic strain.

The Category
Daily Digestive Health Support

Positioned for health-conscious adults managing everyday gut discomfort, bloating, and digestive regularity — a mess-free, no-pills-no-powders format taken anywhere, once a day.

Value Proposition & Architecture

Two validated actives.
One converged product.

GI-PRO™'s defensibility comes from validating both halves of the formulation independently, then proving they work better together than either does alone.

Honey Matrix
Raw Mānuka & Rewarewa Honey
→
PolySure™ Validated
7 polyphenols, ISO 17025, per batch
→
Bioactive Carrier Matrix
prebiotic + polyphenol delivery system
BC30™ Probiotic
Bacillus coagulans GBI-30, 6086®
→
FDA GRAS, Spore-Stable
45+ published safety & efficacy papers
→
2 Billion CFU Standardised Dose
per serve, corrected from 2 million CFU
Converges → GI-PRO™ Daily Digestive Health Snap
One PolySure™-certified Certificate of Analysis documents the polyphenol matrix and the BC30™ CFU count together — a dual validation stack no honey-only or probiotic-only competitor can replicate.
Channel 1
Amazon — US Discovery & Acquisition
Channel 2
D2C Subscription — Margin & Retention
Channel 3
Retail & Food Service — Volume (Future)
Differentiation & IP Moat

Why this can't be
replicated off the shelf.

Our advantage isn't a brand story — it's structural, and it deepens every year through ongoing research.

Validation Standard
MPS PolySure™
An ISO 17025-accredited framework tracking seven key polyphenols per batch — caffeic acid, ferulic acid, quercetin, pinobanksin, chrysin, pinocembrin, and galangin. No competitor quantifies and certifies these seven simultaneously to accredited standard. It's the evidentiary basis for every honey-side label claim GI-PRO™ makes.
Biological Origin
Provenance
GI-PRO™'s polyphenol profile is the direct expression of specific New Zealand ecosystems — soil, altitude, and native flora that exist nowhere else. The supply chain cannot be relocated and the provenance cannot be manufactured. It's a biological fact, validated by science and held under Māori guardianship.
Formulation Know-How
Honey + Probiotic Synergy
Combining a validated honey bioactive matrix with a spore-stable probiotic in a shelf-stable snap format represents years of accumulated formulation science — not published or patentable in isolation, but very hard to reverse-engineer.

This moat compounds through ongoing work: an active, ethics-approved RCT on GI-PRO™ gut microbiome outcomes, an MPI-funded polyphenol validation programme covering 100+ honey varieties, and an untargeted screening programme that has already identified ten putative novel compounds across 112 honey samples. Every study adds a layer that a competitor without our data, our partnerships, and our provenance cannot replicate.

FDA-Compliant Claims Architecture

From ingredient claims
to a defensible functional claim.

Every claim GI-PRO™ makes is built in stages — declared nutrients, to validated ingredient identity, to FDA-recognized functional claims — so the final consumer-facing statement is defensible end to end.

Stage 01
Ingredient Claims
  • NIP panel: naturally occurring carbohydrates, sugars, and minerals declared per serve — clean-label compliant under FDA rules
  • "Naturally occurring source of Quercetin" — validated per batch by PolySure™ UV-SPE (ISO-17025)
  • "Naturally occurring Caffeic Acid" — same validation pathway
  • BC30™ (Bacillus coagulans GBI-30, 6086®) — FDA GRAS, Halal, Kosher, Non-GMO certified
→
Stage 02
Functional Claims
  • "Supports digestive health"
  • "Supports protein absorption" — including plant proteins
  • Backed by 45+ published, peer-reviewed papers confirming BC30™'s safety, stability, and digestive-health efficacy
  • The probiotic earns the claim — the honey delivers it
→
Stage 03
Synergistic Advantage
  • Honey polyphenols (caffeic acid, quercetin, pinobanksin) modulate gut permeability and microbiome diversity — amplifying BC30™'s efficacy
  • Natural prebiotic carbohydrates prime the gut for probiotic uptake — the carrier actively improves delivery, not merely enables it
  • Every batch COA documents the polyphenol matrix alongside the BC30™ CFU count — a dual validation stack competitors can't match
Why this matters commercially: PolySure™'s ISO 17025 accreditation, combined with BC30™'s FDA GRAS status and 45+ published papers, gives GI-PRO™ a defensible label and marketing claim stack across the NIP, structure/function, and ingredient-identity layers simultaneously — a position most single-ingredient probiotic or honey competitors cannot occupy.

These statements have not been evaluated by the Food and Drug Administration. GI-PRO™ is not intended to diagnose, treat, cure, or prevent any disease. Claims sign-off and label review are managed by Dr Lillian Morton PhD, Chief Science Officer.

Customer, Consumer, Market & Channel Fit

Built for the fastest-growing
shelf in US wellness.

Gut health is not a niche — it's the highest-growth segment in the US supplement category we track, and GI-PRO™ is purpose-built for the consumer driving that growth.

Who Takes GI-PRO™
Wellness-Focused Adults
Health-conscious consumers proactively managing total wellness, not just treating symptoms.
Proactive Millennials & Gen-Z
Digitally native, ingredient-literate, and drawn to clean-label, science-backed claims over vague wellness marketing.
Active Lifestylers & Athletes
Consumers who already link gut health to performance and recovery — an audience Mānuka Performance's ambassador network already reaches.
Occasional Gut-Discomfort Sufferers
Adults managing everyday bloating and digestive irregularity — the core symptom set BC30™'s published research addresses.

The purchase driver is convenience as much as efficacy: a single, great-tasting, mess-free daily dose taken anywhere — no pills, no powders, no prep — delivered in a honey format consumers already recognize and enjoy.

US Market Sizing
SegmentMarket Size (TTM)YoY GrowthSeasonality
Gut Health / Probiotics (Amazon)$314M+51%High

Gut Health / Probiotics is the fastest-growing of the eight Amazon wellness segments Mānuka Performance tracks via Channel Key (Cobalt by Jungle Scout data), and one of only two showing strong double-digit growth. Broader context: the US Vitamins, Minerals & Supplements market exceeds $60B; the global functional food and wellness market exceeds $400B; and the gut health category overall is growing 7–10% annually. GI-PRO™ sits directly inside the single highest-growth segment in our addressable market.

Channel Strategy — Amazon → D2C → Retail Flywheel
Discovery & Velocity
Amazon (Primary Acquisition)
The most cost-efficient way to acquire new US gut-health consumers at scale. Channel Key manages PPC, listing optimisation, and category positioning; Amazon provides discovery, reviews, and first-party consumer data.
Margin & Retention
D2C (manukaperformance.com)
Consumers acquired via Amazon convert to D2C for subscription repeat purchasing. No platform fees, higher margin, first-party data — where the long-term unit economics compound.
Volume — Future
Retail & Food Service
Bulk and retail formats extend GI-PRO™'s reach into cafés, wellness retail, and hospitality channels once Amazon/D2C velocity is established.

On Amazon, roughly $8–12 per unit goes to platform fees; on D2C, those fees do not exist — at GI-PRO™'s ~$69 price point, that represents a 17–27 percentage-point margin improvement on direct transactions, reinforcing why Amazon-first, D2C-retained is the deliberate sequencing for this product.

Manufacturing Scale

Auckland as the
production hub.

We are consolidating manufacturing and commercial infrastructure from the Bay of Plenty into Auckland — New Zealand's largest economic centre and most connected international gateway — building toward pharmaceutical-grade (GMP) production.

GMP
Pharmaceutical-grade manufacturing standard — the target certification
AKL
Auckland — production HQ relocation in progress
FDA GRAS
BC30™ probiotic supply — Kerry Group licensed ingredient
Licensable
PolySure™ is a revenue-generating licensable service — not open access

BC30™ is a registered trademark of Kerry Group plc, supplied under license. MPS PolySure™ is not an open-access standard — it is our proprietary validation framework, applied to every GI-PRO™ batch.

Where the Science Is Heading

From nutrition,
toward deeper gut evidence.

GI-PRO™'s R&D programme is deliberately structured to move up the evidence ladder over time — from consumer digestive-health claims today, toward mechanistic gut-microbiome evidence.

Today
Consumer Nutrition Claims
Ethics-approved RCT on GI-PRO™ gut microbiome outcomes, mood, and sleep — generating defensible label and ingredient claims for the US market.
→
Building Now
Compound Characterisation
Untargeted LC-HRMS screening has identified ten putative novel compounds across 112 honey samples — the pathway to reference standards and patent-protectable IP.
→
Emerging
Gut-Brain Axis Evidence
Research extending into the gut-brain axis and broader mechanistic evidence — building toward a deeper clinical evidence base for GI-PRO™.

This is a deliberate sequencing choice, not a promise of a therapeutic outcome: consumer revenue funds the science, and the science funds deeper characterisation of GI-PRO™'s honey-and-probiotic matrix.